Free Diabetes CME and Free Endocrinology CME | CMEList.com

 


The Evolution of Insulin Replacement Therapy: New Perspectives and Clinical Applications Free Diabetes CME
Live online September 14, 2017, October 19, 2017 and November 30, 2017 (2 sessions) and available on demand through May 30, 2018.
Posted by...Bernard Sklar, MD.
Free Diabetes CME Credit hours...4.0. 
CME Credits Awarded by....Joslin Diabetes Center.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for US-based primary care providers, clinical endocrinologists/diabetologists, nephrologists, cardiologists, emergency department specialists, pharmacists, and other clinicians caring for patients with type 2 diabetes mellitus (T2DM).
Educational material updated....September 14, 2017.
Expiration of CME credit...May 30, 2018.
Financial Support...Novo Nordisk Inc. and Medtronic, Inc.
The Evolution of Insulin Replacement Therapy consists of 4 presentations with discussion:
• Session 1: Insulin Options for Diabetes: Update on their Evolution
• Session 2: Advancing to Insulin Therapy for Type 2 Diabetes: The Impact of the New Insulin Options
• Session 3: Physiologic Insulin Replacement: Practical Approaches for the Primary Care Provider
• Session 4: The Evolution of Glycemic Monitoring and Insulin Delivery Devices: Why the Primary Care Provider Should Understand the Options
At the conclusion of The Evolution of Insulin Replacement Therapy, you will be able to:
• Identify clinically relevant pharmacokinetic and pharmacodynamic properties of the new insulins and insulin combinations
• Discuss the clinical importance of similarities and differences between a biosimilar insulin and a reference insulin
• Recognize the indications for advancement to insulin replacement therapy for people with T2DM
• Identify clinically relevant pharmacokinetic and pharmacodynamic properties of the new insulins and insulin combinations
• Describe initiation and titration methods for new insulin-based therapies to optimize achievement of glycemic goals while minimizing adverse effects
• Discuss strategies to overcome patient and clinician barriers to the successful initiation and utilization of insulin therapy in the context of the new insulin-based therapies, and monitoring and delivery devices

Concentrated Insulins in Clinical Practice: Pharmacology and Treatment Designs Free Diabetes CME
Live online June 21, 2017 and available on demand through December 21, 2017.
Posted by...Bernard Sklar, MD.
Free Diabetes CME Credit hours..1.0.
CME Credits Awarded by....Joslin Diabetes Center. Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...This program is intended for diabetes specialty care providers, including diabetologists, endocrinologists, and internists. Also, diabetes educators and pharmacists with significant numbers of patients/clients with diabetes and physicians who care for a significant number of people with diabetes and insulin resistance and who might be involved in design or management of glycemic control programs, including general internists, cardiologists and nephrologists.
Educational material updated...June 21, 2017.
Expiration of CME credit...December 21, 2017.
Financial Support...Lilly.
Concentrated Insulins in Clinical Practice: Pharmacology and Treatment Designs consists of 3 topics with discussion:
• Optimizing Basal Insulin Therapy: Implementation, Management, and Overcoming Barriers
• Optimizing Basal Insulin Therapy: Evolving Tools and Treatment Designs
• Concentrated Insulins in Clinical Practice: Pharmacology and Treatment Designs
After viewing Concentrated Insulins in Clinical Practice: Pharmacology and Treatment Designs, you will be better able to :
• Compare the pharmacokinetic and pharmacodynamic properties of concentrated insulins that are used to treat people with diabetes, particularly those with significant insulin resistance
• Recognize the indications for and methods to utilize concentrated insulins to treat type 2 diabetes, including people with significant insulin resistance
• Identify barriers preventing the use of concentrated insulins in your practice and enhance skills in mentoring the use of these treatment tools when indicated

Hyperkalemia: Causes, Consequences, and Treatment
Free Hyperkalemia CME Posted by...Bernard Sklar, MD.
Free CME Credit Hours...0.75.
CME Credits Awarded by...Vindico Medical Education.
Cost for Credit...Free.
Instruction Type...Video Lectures.
Target Audience...Nephrologists, endocrinologists, cardiologists, internal medicine physicians, primary care physicians and other health care professionals involved in the treatment of patients with hyperkalemia.
Educational material last updated...December 14, 2016.
CME Credit Expires...December 13, 2017.
Financial Support...Relypsa, Inc.
Hyperkalemia: Causes, Consequences, and Treatment consists of three brief video presentations on hyperkalemia.
Upon successful completion of Hyperkalemia: Causes, Consequences, and Treatment, you should be better able to:
• Describe the pathophysiology of hyperkalemia, etiologic factors associated with its presentation, and its potential effect on multiple organ systems.
• Review the symptoms that commonly present in patients with hyperkalemia to assist in determining the appropriate diagnostic follow-up.
Differentiate among the new and emerging agents for hyperkalemia for improved treatment selection.
• Apply the efficacy and safety data of conventional therapy and emerging treatments when selecting therapy for hyperkalemia in patients with chronic kidney disease or end-stage renal disease and chronic heart failure.
• Select the appropriate treatment for patients with diabetes and hyperkalemia.

Treatment strategies in Hunter Syndrome Free Genetics CME
Posted by...Bernard Sklar, MD.
Free Pulmonology and Genetics CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Cost..........Free.
Instruction Type....Slide-Video Lectures.
Target Audiences....Pediatricians, neurologists, endocrinologists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists; and any other healthcare professionals with an interest in or who may clinically encounter patients with Hunter syndrome.
Educational material last updated...June 29, 2017.
Expiration of CME credit...June 29, 2019.
Financial Support...Shire.
Hunter syndrome is an X-linked recessive genetic disease characterized by a deficiency of lysosomal enzymes responsible for the hydrolysis of glycosaminoglycans (GAGs), with males more likely to develop disease and females more likely to be carriers.
After reviewing Treatment strategies in Hunter Syndrome, you will be able to:
• Describe the importance of earlier treatment and diagnosis of Hunter syndrome in patients
• Determine the likelihood of Hunter syndrome using with established diagnosis methods, given a patient case
• Describe options available to treat Hunter syndrome and design a medical plan to treat a patient with Hunter syndrome
• Describe present barriers to care in the treatment of patients with Hunter syndrome

Adult Growth Hormone Deficiency (GHD): Therapeutic Updates, Present Clinical Controversies, and Barriers to Care Free Endocrinology CME
Posted by...Bernard Sklar, MD.
Free Endocrinology CME Credit hours...0.75.
CME Credits Awarded by....ScientiaCME.
Cost...........Free.
Instruction Type...Streaming Video Lecture and discussion.
Target Audiences...Healthcare professionals specializing in endocrinology and those who otherwise commonly care for or clinically encounter adult patients with GHD.
Educational material updated...July 12, 2016.
Expiration of CME credit...July 12, 2018.
Financial Support...Novo Nordisk.
After completing Adult Growth Hormone Deficiency (GHD), you will be able to:
• Summarize present guidelines for the diagnosis of GHD
• Describe the underlying pathophysiological and typical clinical features of GHD as they pertain to therapeutic targets.
• Given a patient with GHD, design a pharmacotherapeutic regimen based on his or her clinical presentation.
• Assess and properly manage the significant comorbidities that are associated with GHD and therefore increase mortality in patients with GHD
• Evaluate patient cases during follow-up visits in a manner that optimizes one or more of the following: efficacy, safety, quality of life, or patient education and adherence.
In order to get credit from ScientiaCME, you must first establish a username and password.